Kymera Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Kymera Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Kymera Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kymera Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $9.1M | 228k | 40.20 |
| 2023-12-31 | $4.2M | 164k | 25.46 |
| 2023-09-30 | $519k | 37k | 13.90 |
| 2023-06-30 | $1.1M | 48k | 22.99 |
| 2023-03-31 | $1.0M | 35k | 29.63 |
| 2022-12-31 | $805k | 32k | 24.96 |
| 2022-09-30 | $685k | 32k | 21.68 |
| 2022-06-30 | $456k | 23k | 19.61 |
| 2022-03-31 | $986k | 23k | 42.32 |
| 2021-12-31 | $1.2M | 20k | 63.48 |
| 2021-09-30 | $971k | 17k | 58.49 |
| 2021-06-30 | $327k | 6.7k | 48.94 |
| 2021-03-31 | $576k | 9.8k | 58.82 |
| 2020-12-31 | $1.1M | 11k | 100.00 |